Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
<p>Statistics from DESeq2</p>
Tallennettuna:
| Päätekijä: | Alyssa C. Flint (16676029) (author) |
|---|---|
| Muut tekijät: | Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author) |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Tekijä: Alyssa C. Flint (16676029)
Julkaistu: (2025) -
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Tekijä: Elizabeth R. Tucker (15053624)
Julkaistu: (2025) -
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Tekijä: Elizabeth R. Tucker (15053624)
Julkaistu: (2025) -
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Tekijä: Elizabeth R. Tucker (15053624)
Julkaistu: (2025) -
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Tekijä: Elizabeth R. Tucker (15053624)
Julkaistu: (2025)